RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
  NHS
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
NHS Channel

subscribe to NHS newsletter
Healthcare : UK : NHS

   EMAIL   |   PRINT
New Guideance will Result in Better Control of Hypertension - BPA

Jun 29, 2006 - 1:45:00 AM , Reviewed by: Sanjukta Acharya
"Living with high blood pressure can be very difficult. We know from our own research that beta-blockers commonly cause side effects, including tiredness, lethargy, impotence and mood swings, and can enormously impact on that individual and their family's quality of life."

 
[RxPG] The UK's blood pressure charity, the Blood Pressure Association (BPA), heralded 28 June, 2006 launch of the updated NICE guideline on the clinical management of hypertension as a major advance in the treatment of the condition. For the first time, NICE and the British Hypertension Society have reached a clear consensus on the best way of treating raised blood pressure, and the BPA strongly endorses this new guideline.

Professor Graham MacGregor, Chairman of the Blood Pressure Association, said: "This is a major step forward in the treatment of high blood pressure and tremendous news for the millions of people in this country with the condition.

"The new guideline can easily be followed by health professionals and people with high blood pressure. The net result will be much better control of blood pressure with far fewer strokes, heart attacks and heart failure. This is particularly so because the treatment combinations suggested are more effective and have less side effects."

A major change is that beta-blockers, which have been shown to be less effective in reducing strokes and more likely to cause diabetes2, are no longer recommended for the routine treatment of the majority of people with high blood pressure.

"Access to more effective drugs will be really welcomed by patients and will have implications, not only for the newly diagnosed, but for the many millions of people already on beta-blockers," said Professor MacGregor.

High blood pressure is the biggest preventable cause of death and disability in the UK through the strokes, heart attacks and heart failure that it causes. Poor blood pressure control results in approximately 125,000 unnecessary stroke and heart attack events every year, about half of which are fatal3.

Sarah Ransome, BPA Head of Information and Support, said: "Living with high blood pressure can be very difficult. We know from our own research that beta-blockers commonly cause side effects, including tiredness, lethargy, impotence and mood swings, and can enormously impact on that individual and their family's quality of life.

"The new guideline will result in better control of blood pressure by giving patients access to the best available treatments and encouraging dialogue between patients and their health professionals so that they can make informed decisions about their care."
New Guideance will Result in Better Control of Hypertension - BPA

Professor MacGregor added: "We would encourage those people currently taking beta-blockers to talk to their GP or health professional on their next visit to discuss whether changing the medication in the fullness of time to newer medicines would be appropriate for them. People should not stop taking beta-blockers on their own as this will do far more harm than good. Furthermore, beta-blockers will continue to have an important role in the treatment of angina, heart failure and following a heart attack, or in women of child-bearing age with high blood pressure."



Publication: Blood Pressure Association (BPA)
On the web: www.bpassoc.org.uk 

Advertise in this space for $10 per month. Contact us today.


Related NHS News
Systematic bias in the assessment of UK doctors
Depression is wrongly seen as natural part of getting older
NRI doctor guilty of unethical tests on British patients
New steps to curb overseas doctors in Britain
Should EU patient information laws be relaxed?
Institutional discrimination by NHS causing unnecessary deaths of people with a learning disability
Should the NHS curb spending on translation services?
The NHS Redress Act may lead to more complaints
Patients should cc the benefits of doctors' letters
Is doctors' pay responsible for the financial crisis in the NHS ?

Subscribe to NHS Newsletter

Enter your email address:


 Additional information about the news article
The Blood Pressure Association is the only UK charity dedicated to the prevention, diagnosis and treatment of high blood pressure. National Institute for Health and Clinical Excellence is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health. 16 million people in the UK have high blood pressure, but a third of those aren’t aware of it. High blood pressure is diagnosed as 140/90mmHg or above.

References:

1. Hypertension-Management of hypertension in adults in primary care. June 2006. http://www.nice.org.uk/page.aspx?o=CG34

2. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; for the ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the ASCOT-Blood Pressure Lowering Arm (ASCOT-BPLA):multicentre randomised controlled trial. Lancet 2005;366:895-906.

3. He FJ, MacGregor GA. Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens. 2003;17:455-7.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)